CSIMarket
 


Immuron Limited  (IMRN)
Other Ticker:  
 
 

IMRN's EPS from Cont. Operations Growth by Quarter and Year

Immuron Limited's EPS from Cont. Operations results by quarter and year




IMRN EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -1.25 0.00 -1.66 -3.20
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -1.25 0.00 -1.66 -3.20



IMRN EPS from Cont. Operations forth quarter 2022 Y/Y Growth Comment
Immuron Limited in the forth quarter 2022 recorded EPS loss from Cont. Operations of $ -1.25 .

According to the results reported in the forth quarter 2022, Immuron Limited achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Immuron Limited' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the forth quarter 2022.




IMRN EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Immuron Limited's forth quarter 2022 EPS from Cont. Operations $ -1.25 IMRN's Income Statement
Immuron Limited's forth quarter 2021 EPS from Cont. Operations $ 0.00 Quarterly IMRN's Income Statement
New: More IMRN's historic EPS from Cont. Operations Growth >>


IMRN EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Immuron Limited's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMRN's IV. Quarter Q/Q EPS from Cont. Operations Comment


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMRN's IV. Quarter Q/Q EPS from Cont. Operations Comment


Immuron Limited's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Jun 30 2019)
12 Months Ending
Cumulative EPS from Cont. Operations 12 Months Ending $ -1.25 $ 0.00 $ -1.66 $ -3.20 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Immuron Limited' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jun 30 2022 period.
The business is getting worse as the cumulative EPS loss from Cont. Operations is becoming larger from $ 0 for the period from Jun 30 2021 to and $ 0 from the TTM period ending .

Immuron Limited achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Immuron Limited' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jun 30 2022 period.
The results are detiriorating as the cumulative EPS loss from Cont. Operations is becoming larger from $ 0 in TTM ending quarter Jun 30 2021 and $ 0 from the TTM period ending .

Immuron Limited achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
IMRN's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for IMRN's Competitors
EPS from Cont. Operations Growth for Immuron Limited's Suppliers
EPS from Cont. Operations Growth for IMRN's Customers

You may also want to know
IMRN's Annual Growth Rates IMRN's Profitability Ratios IMRN's Asset Turnover Ratio IMRN's Dividend Growth
IMRN's Roe IMRN's Valuation Ratios IMRN's Financial Strength Ratios IMRN's Dividend Payout Ratio
IMRN's Roa IMRN's Inventory Turnover Ratio IMRN's Growth Rates IMRN's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Jun 30 2022
Te Connectivity ltd -27.17%$ -27.168 
Regen Biopharma Inc -70.00%$ -70.000 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PAVM's Profile

Stock Price

PAVM's Financials

Business Description

Fundamentals

Charts & Quotes

PAVM's News

Suppliers

PAVM's Competitors

Customers & Markets

Economic Indicators

PAVM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071